Dr. Rebbeck: CancerInMass website provides data and resources on cancer incidence and mortality

May 03, 2022

CancerInMass website provides data and resources on cancer incidence and mortality
Making cancer risk data in MA – by location – easier to view than ever before

For Immediate Release, May 3, 2022

Boston, MA – A new website provides data and resources on cancer incidence and mortality to aid public health officials, community groups and researchers. Cancer is the leading cause of death among Massachusetts residents and the Centers for Disease Control and Prevention reports that cancer kills more Massachusetts residents than heart disease, accidents, stroke, infectious disease, or diabetes.

The Center for Cancer Equity and Engagement (CCEE) within the Dana-Farber/Harvard Cancer Center (DF/HCC), is launching the Cancer in Massachusetts website (CancerInMass.org) to provide information about cancer for Massachusetts residents as well as researchers, public health officials, communities, and other groups. This web site, which was developed in collaboration with the Center for Geographic Analysis, Harvard University, summarizes cancer risk factors and cancer occurrences from the Massachusetts State Cancer Registry and the National Cancer Institute SEER*Stat system, and describes disparities by race, ethnicity, and gender that represent an unequal cancer burden in specific groups. The information is presented for the Commonwealth of Massachusetts and for each of its 14 counties.

“We believe that these data can help people to understand more fully the cancer burden, and act to address this burden in the Commonwealth,” said Timothy Rebbeck, PhD, Associate Director for Community Outreach and Engagement for DF/HCC. “The information we present can help identify areas and groups of people who require special attention to limit the impact of cancer in their communities.”

Visit the DF/HCC website for the latest news and press releases.

###

Dana-Farber/Harvard Cancer Center (DF/HCC), an NCI-designated comprehensive cancer center, was founded to integrate and build upon the collective talent and resources of the Harvard cancer research community. Five Boston academic medical institutions—Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital—and two Harvard Schools—the Harvard Medical School and the Harvard T.H. Chan School of Public Health—combined their scientific strengths to create a rich, collaborative environment that transcends institutional borders. DF/HCC is the powerful successor organization to the Dana-Farber Cancer Institute Comprehensive Cancer Center, one of the original cancer centers designated by the NCI in 1973.